CVS Caremark (CVS)
CVS - NYSE - 3/12/2010 8:00 PM
| Market Cap | Revenue Growth | Profit Margin | Cash |
|---|---|---|---|
| $48.85B | 6.96% | 4.06% | $1.09B |
| 78 / 4569 | 1409 / 4568 | 2214 / 4566 | 415 / 4096 |
For the December 2009 quarter, CVS Caremark spent 0% of gross profits on R&D and 65.96% on SGA expenses. Revenues rose 6.96% year-over-year to $25.82B. The company is trading at 13.58 times earnings(PE) and 0.49 times revenue(PSR). At the end of December 2009, CVS Caremark had $1.09B in cash on hand and $8.76B in long-term debt. On 02/08/2010, CVS Caremark reported net income of $1.05B, with diluted earnings per share of $0.74.
